Central banks catch their breath: Will biotech shine again as rates stop rising?
Rate hikes tend to be bad news for ‘jam tomorrow’ sectors but the cycle is ending
Author: Sarah Godfrey
-
-
Japanese trusts: Is it dangerous to believe ‘this time it is different’?
Japan has been more ‘Land of the False Dawn’ than ‘Land of the Rising Sun’ for investors over the past 30 years
-
From marketing slogan to political alliance: Can BRICS challenge the status quo?
Following the expansion of the BRICS group, investors discuss which constituents offer the best opportunities
-
What do ‘higher for longer’ interest rates mean for UK smaller companies?
Martin Currie’s Richard Bullas and Dan Green explain why UK small and mid caps could ‘come back like a coiled spring’
-
Soft landing or soft economy – what do rising bond yields signal?
Are bonds a good or bad investment in the current environment?
-
Are UK investors really turning their backs on Europe?
European equity funds have been among the worst-selling OEICs in 2023 to date, yet they remain the fifth-largest IA sector by AUM
-
Have larger mid-cap trusts found themselves in ‘the danger zone’?
Consolidation and short-sellers of the FTSE 250 index have created a ‘perfect storm’
-
Consolidation, overcrowding and widening discounts: Do investment trust boards need to step up?
Given the Home Reit saga and TLEI’s suspended shares, PA looks at governance concerns in the investment trust space
-
Digital infrastructure trusts: Tapping into the fourth industrial revolution
Where are the best opportunities in the digital infrastructure space?
-
Building the case for infrastructure
What are the arguments for and against including infrastructure in a balanced portfolio?
-
A deep dive into the most popular investment trusts of H1 2023
Why UK equity income trusts are proving more popular than their open-ended counterparts
-
Cash is king – but not how you might think
Macro conditions could help UK stocks recover versus peers